tradingkey.logo

Inmode Ltd

INMD
查看詳細走勢圖
13.400USD
-0.350-2.55%
收盤 03/27, 16:00美東報價延遲15分鐘
856.17M總市值
9.23本益比TTM

Inmode Ltd

13.400
-0.350-2.55%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-2.55%

5天

-0.96%

1月

-2.55%

6月

-10.07%

今年開始到現在

-8.78%

1年

-24.29%

查看詳細走勢圖

TradingKey Inmode Ltd股票評分

單位: USD 更新時間: 2026-03-27

操作建議

Inmode Ltd當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名68/208位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為16.80。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Inmode Ltd評分

相關信息

行業排名
68 / 208
全市場排名
176 / 4542
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Inmode Ltd亮點

亮點風險
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
估值合理
公司最新PE估值9.23,處於3年歷史合理位
機構減倉
最新機構持股37.36M股,環比減少28.82%
Hotchkis & Wiley持倉
明星投資者Hotchkis & Wiley持倉,最新持倉864.14K股

分析師目標

基於 7 分析師
持有
評級
16.800
目標均價
+22.63%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Inmode Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Inmode Ltd簡介

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
公司代碼INMD
公司Inmode Ltd
CEOMizrahy (Moshe)
網址https://inmodemd.com/
KeyAI